InflaRx
IFRX
38 hedge funds and large institutions have $459M invested in InflaRx in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
40% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 10
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
12% more funds holding
Funds holding: 34 → 38 (+4)
11% more capital invested
Capital invested by funds: $414M → $459M (+$45.2M)
2.15% more ownership
Funds ownership: 50.69% → 52.84% (+2.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Scopia Capital Management
New York
|
+$6.61M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$5.73M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$5.36M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.03M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
+$2.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$4.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$3.57M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
-$2.58M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$90.3K |
| 5 |
D.E. Shaw & Co
New York
|
-$88.7K |
IFRX Hedge Fund Activity: Q3 2018 in Review
38 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q3 2018, worth a combined $459M — up 11% from $414M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new IFRX positions and 4 closed out — a net gain of 4 holders — while 14 added to existing stakes and 10 trimmed.
The largest buyer was Scopia Capital Management, opening a new position worth an estimated $6.61M. The largest seller was Cormorant Asset Management, cutting an estimated $4.7M.
- 38 institutional investors held InflaRx (IFRX) as of Q3 2018, up from 34 in Q2 2018.
- Funds reported $459M of InflaRx stock for Q3 2018, up 11% quarter-over-quarter.
- 8 funds opened new InflaRx positions in Q3 2018 and 4 closed out, a net change of +4 holders.
- The largest InflaRx buyer in Q3 2018 was Scopia Capital Management, an estimated $6.61M added.
- The largest InflaRx seller in Q3 2018 was Cormorant Asset Management, an estimated $4.7M sold.
Based on aggregated 13F filings for Q3 2018.